Write your message
Volume 7, Issue 6 (November - December 2022)                   J Obstet Gynecol Cancer Res 2022, 7(6): 497-506 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Behaile Teklemariam A, Kelta Wabalo E, Adugna Leta T, Shimeles Assefa S, Chekol Abebe E. Evaluation of Lactate Dehydrogenase and Gamma Glutamyl Transferase Among Pregnant Women with Hypertensive Disorders and Their Association with Disease Severity in Jimma Medical Center, Ethiopia. J Obstet Gynecol Cancer Res 2022; 7 (6) :497-506
URL: http://jogcr.ir/article-1-552-en.html
1- Department of Biochemistry, College of Health Sciences, Debre Tabor University, Debre Tabor, Ethiopia , awgich85behaile@gmail.com
2- Department of Biomedical Sciences, Institute of Health Sciences, Jimma University, Jimma, Ethiopia
3- Department of Biochemistry, College of Health Sciences, Debre Tabor University, Debre Tabor, Ethiopia
Abstract:   (724 Views)

Background & Objective: Pregnancy-induced hypertensive disorders (PIHD) are the main reasons for maternal and perinatal mortality, as they complicate 10% of pregnancies worldwide. Serum lactic acid dehydrogenase (LDH) and gamma-glutamyl transferase (GGT) are possible markers reflecting the occurrence of pregnancy-associated complications like preeclampsia and eclampsia. There is a paucity of data with conflicting results showing serum LDH and GGT on PIHD in Ethiopia. This investigation aimed to assess the serum LDH and GGT levels in pregnant women with PIHD along with their correlation with the severity of the disease at Jimma Medical Center (JMC), Ethiopia.
Materials & Methods: This hospital-based comparative cross-sectional study was undertaken from August 03 to September 27, 2020, in JMC. A total of 97 study participants were recruited. Serum GGT and LDH levels were determined using a fully automated Roche Cobas 6000 chemistry analyzer. The data were analyzed using SPSS 25.0. One-way ANOVA and independent samples t-test were employed to compare serum GGT and LDH levels with categories of PIHD.
Results: The significantly highest mean serum levels of LDH (580.9±193.8 U/L) and GGT (86.1±29.2 U/L) were observed in eclamptic women compared to gestational hypertensive (276.7±60.7 and 38.3±16.9 U/L) and preeclamptic patients (353±132.8 and 48.8±29.9 U/L), respectively. Both serum GGT and LDH levels were found to correlate with the severity of preeclampsia, respectively significantly.
Conclusion: Serum LDH and GGT were found to be at the highest levels in eclamptic than preeclamptic and gestational hypertensive women. Blood pressure, gestational age, and severity of hypertensive disorders of pregnancy were predictor variables associated with serum GGT and LDH.

Full-Text [PDF 478 kb]   (153 Downloads) |   |   Full-Text (HTML)  (81 Views)  
Systematic Review: Original Research | Subject: Obstetrics and Gynecology
Received: 2021/11/17 | Accepted: 2022/02/23 | Published: 2022/09/9

1. Leeman L, Fontaine P. Hypertensive disorders of pregnancy. Am Fam Physician. 2008;78(1):93-100.
2. Braunthal S, Brateanu A. Hypertension in pregnancy: Pathophysiology and treatment. SAGE Open Med. 2019;7:2050312119843700. [DOI:10.1177/2050312119843700] [PMID] [PMCID]
3. Brown MA, Magee LA, Kenny LC, Karumanchi SA, McCarthy FP, Saito S, et al. Hypertensive disorders of pregnancy: ISSHP classification, diagnosis, and management recommendations for international practice. Hypertension. 2018;72(1):24-43. https://doi.org/10.1161/HYPERTENSIONAHA.113.01833 [DOI:10.1161/HYPERTENSIONAHA.117.10803]
4. Ye C, Ruan Y, Zou L, Li G, Li C, Chen Y, et al. The 2011 survey on hypertensive disorders of pregnancy (HDP) in China: prevalence, risk factors, complications, pregnancy and perinatal outcomes. PloS One. 2014;9(6):e100180. [DOI:10.1371/journal.pone.0100180] [PMID] [PMCID]
5. Roberts JM, Pearson G, Cutler J, Lindheimer M. Summary of the NHLBI working group on research on hypertension during pregnancy. Hypertension. 2003;41(3):437-45. [DOI:10.1161/01.HYP.0000054981.03589.E9] [PMID]
6. Lindheimer MD, Taler SJ, Cunningham FG. Hypertension in pregnancy. J Am Soc Hypertens. 2008;2(6):484-94. [DOI:10.1016/j.jash.2008.10.001] [PMID]
7. Campbell SK, Lynch J, Esterman A, McDermott R. Pre-pregnancy predictors of hypertension in pregnancy among Aboriginal and Torres Strait Islander women in north Queensland, Australia; a prospective cohort study. BMC Public Health. 2013;13(1):1-9. [DOI:10.1186/1471-2458-13-138] [PMID] [PMCID]
8. Munde S, Hazari N, Thorat A, Gaikwad S, Hatolkar V. Gamma glutamyl transferase and Lactate dehydrogenase as biochemical markers of severity of preeclampsia. Int J Med Healt Biomed Bioengineering Pharm Eng. 2014;8(1):50-3.
9. Fazal RS, Chandru S, Biswas M. Evaluation of total LDH and its isoenzymes as markers in preeclampsia. J Med Biochem. 2019;39(3):392-8. [DOI:10.2478/jomb-2019-0045] [PMID] [PMCID]
10. Leeman L, Dresang LT, Fontaine P. Hypertensive disorders of pregnancy. Am Fam Physician. 2016;93(2):121-7.
11. Townsend R, O'Brien P, Khalil A. Current best practice in the management of hypertensive disorders in pregnancy. Integr Blood Press Control. 2016;9:79. [DOI:10.2147/IBPC.S77344] [PMID] [PMCID]
12. Saxena S, Srivastava PC, Thimmaraju K, Mallick AK, Dalmia K, Das B. Socio-demographic profile of pregnancy induced hypertension in a tertiary care centre. Sch J Appl Med Sci. 2014;2(6D):3081-6.
13. Bhave NV, Shah PK. A correlation of lactate dehydrogenase enzyme levels in pregnancy induced hypertensive disorders with severity of disease, maternal and perinatal outcomes. Int J Reprod Contracept Obstet Gynecol. 2017;6(10):4302-8. [DOI:10.18203/2320-1770.ijrcog20174132]
14. Popovski N, Nikolov A. Practice Bulletin of the American College of Obstetrics and Gynaecologists 2019 on Magement of Hypertensive Disorders in Pregnancy-A Short Review of the Current Recommendations. Biomed J Sci Technol Res. 2019;23(2):17198-201. [DOI:10.26717/BJSTR.2019.23.003861]
15. Mehta M, Parashar M, Kumar R. Serum lactate dehydrogenase: a prognostic factor in pre-eclampsia. Int J Reprod Contracept Obstet Gynecol. 2019;8(7). [DOI:10.18203/2320-1770.ijrcog20193044]
16. Mason JE, Starke RD, Van Kirk JE. Gamma‐Glutamyl transferase: a novel cardiovascular risk BioMarker. Prev Cardiol. 2010;13(1):36-41. [DOI:10.1111/j.1751-7141.2009.00054.x] [PMID]
17. Wu J, Zhou W, Li Q, Yuan R, Li H, Cui S. Combined use of serum gamma glutamyl transferase level and ultrasonography improves prediction of perinatal outcomes associated with preeclamptic pregnancy. Clin Chim Acta. 2017;475:97-101. https://doi.org/10.1016/j.aca.2017.01.015 [DOI:10.1016/j.cca.2017.09.018]
18. Fornaciari I, Fierabracci V, Corti A, Aziz Elawadi H, Lorenzini E, Emdin M, et al. Gamma-glutamyltransferase fractions in human plasma and bile: characteristic and biogenesis. PLoS One. 2014;9(2):e88532. [DOI:10.1371/journal.pone.0088532] [PMID] [PMCID]
19. Balakrishna S, Prabhune AA. Gamma-glutamyl transferases: A structural, mechanistic and physiological perspective. Front Biol. 2014;9(1):51-65. [DOI:10.1007/s11515-014-1288-0]
20. Patil RR, Choudhari AS. Evaluation of Activities of Serum Gamma Glutamyl Transferase and Adenosine Deaminase in Pre-Eclampsia-A Case Control Study. J Med Res. 2016;6(4):313-5.
21. Nosrat BS, Azarhoosh R, Borghei A, Sedaghati M, Besharat S, Ghaemi E. Serum level of Lactate dehydrogenase, Homocystein, Hemoglobin and platelet in preeclampsia. Pak J Med Sci. 2011;27(5):1014-7.
22. Gruccio S, Di Carlo MB, Pandolfo M, Santa Cruz G, Touzon MS, Negri G, et al. Biochemical profiling study in umbilical cord blood as predictors of neonatal damage. Int J Clin Pediatr. 2014;3(1):5-11. [DOI:10.14740/ijcp140e]
23. Qublan H, Ammarin V, Bataineh O, Al-Shraideh Z, Tahat Y, Awamleh I, et al. Lactic dehydrogenase as a biochemical marker of adverse pregnancy outcome in severe pre-eclampsia. Med Sci Monit. 2005;11(8):CR393-CR7.
24. Afroz R, Akhter QS, Sadia H, Sultana S. Serum Lactate Dehydrogenase (LDH) level in severe preeclampsia. J Bangladesh Soc physiol. 2015;10(2):71-5. [DOI:10.3329/jbsp.v10i2.27168]
25. Andrews L, Patel N. Correlation of serum lactate dehydrogenase and pregnancy induced hypertension with its adverse outcomes. Int J Res Med Sci. 2016;4(5):1347-50. [DOI:10.18203/2320-6012.ijrms20161112]
26. Shojaei K, Jafari RM, Haghighat F. Comparison of the Level of Uric Acid and LDH in Mothers in Early and Late Preeclampsia and Determination of Its Association with the Severity of Preeclampsia. J Biochem Tech. 2019;2:36-8.
27. Umasatyasri Y, Vani I, Shamita P. Role of LDH (Lactate dehydrogenase) in preeclampsia-eclampsia as a prognostic marker: An observational study. IAIM. 2015;2(9):88-93.
28. Kasraeian M, Asadi N, Vafaei H, Zamanpour T, Shahraki HR, Bazrafshan K. Evaluation of serum biomarkers for detection of preeclampsia severity in pregnant women. Pak J Med Sci. 2018;34(4):869. [DOI:10.12669/pjms.344.14393] [PMID] [PMCID]
29. Jaiswar S, Gupta A, Sachan R, Natu S, Shaili M. Lactic dehydrogenase: a biochemical marker for preeclampsia-eclampsia. J Obstet Gynaecol India. 2011;61(6):645-8. [DOI:10.1007/s13224-011-0093-9] [PMID] [PMCID]
30. Vanishree B, Dayanand C, Sheela S. Can GGT and LDH be indicators of endothelial vascular damage in Preeclampsia? Int J Clin Biochem Res. 2019;6(4):571-4. [DOI:10.18231/j.ijcbr.2019.118]
31. Sarkar PD, Sogani S. Evaluation of serum lactate dehydrogenase and gamma glutamyl transferase in preeclamptic pregnancy and its comparison with normal pregnancy in third trimester. Int J Res Med Sci. 2013;1(4):365-8.
32. Elias SES, Eltom A, Osman AL, Babker AM. Gamma glutamyl transferase and lactate dehydrogenase as biochemical markers of severity of preeclampsia among Sudanese pregnant women. Int J Reprod Contracept Obstet Gynecol. 2018;7(8):3020-3. [DOI:10.18203/2320-1770.ijrcog20183294]
33. Kulkarni VV, Shaikh B. To Study Levels of LDH in Normal Pregnancy, Pre-Eclampsia & Eclampsia. J Evol Med Dent Sci. 2019;8(35):2768-73. [DOI:10.14260/jemds/2019/600]
34. Dave A, Maru L, Jain A. LDH (lactate dehydrogenase): a biochemical marker for the prediction of adverse outcomes in pre-eclampsia and eclampsia. J Obstet Gynaecol India. 2016;66(1):23-9. [DOI:10.1007/s13224-014-0645-x] [PMID] [PMCID]
35. Sumathi M, Joshi RU, Gomathy E, Shashidhar K. Usefulness of serum gamma glutamyl transferase in assessing severity of preeclampsia. Int J Clin Biochem Res. 2016;3(2):245-9. [DOI:10.5958/2394-6377.2016.00047.2]
36. Dev SV, Hemalatha C. Evaluation of lactate dehydrogenase-a biochemical marker of preeclampsia. J Evol Med Dent Sci. 2017;6(79):5572-5. [DOI:10.14260/jemds/2017/1209]
37. Talwar P, Kondareddy T, Shree P. LDH as a prognostic marker in hypertensive pregnancy. Int J Reprod Contracept Obstet Gynecol. 2017;6(6):2444-6. [DOI:10.18203/2320-1770.ijrcog20172328]

Add your comments about this article : Your username or Email:

Send email to the article author

Rights and permissions
Creative Commons License Journal of Obstetrics, Gynecology and Cancer Research by Farname Inc is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. Based on a work at http://jogcr.com/.

© 2023 CC BY-NC 4.0 | Journal of Obstetrics, Gynecology and Cancer Research (JOGCR)

Designed & Developed by : Yektaweb | Piblisher: Farname Inc.